AWH aspirawh.com Company Projected Revenue

Official company branding of Aspira Women's Health Inc. (AWH)

Aspira Women's Health revenues depend on insurance coverage for Ova1Plus tests and diagnostic accuracy. The company's projected sales level reflects the current vector of market expectations, where 0.01 determines this parameter level. An expanding client base of gynecologists is broadening the market, while strategic alliances with laboratories are increasing the efficiency of early pathology detection.

AWH - Aspira Women's Health Company Future Sales over the range 07/04/2022 - 04/26/2025

Analytical breakdowns for Aspira Women's Health

- stock value and consensus price forecast:
Fundamental valuation:Aspira Women's Health, Inc. AWH
Brand item of Aspira Women's Health Inc

This indicator reflects the asset's market value as an integral measure of operational management quality. Investors compare calculation dynamics with business efficiency, utilizing the firm's sales volume expectations to analyze discounted cash flows. Any local peak signals a risk of overpaying for the asset. For Aspira Women's Health (AWH), this metric confirms the commercial potential of the OVA1 platform. The integration of tests into clinical guidelines ensures stable revenue growth.

Competitors of Aspira Women's Health

Company Projected Revenue Agilent (A)|Projected Sales Volume Quest Diagnostics Incorporated (DGX)|Company Projected Revenue Illumina Corp ILMN|EXAS: Company Revenue Forecast|RVTY: Company Future Sales Volume|Company Sales Forecast bio-rad.com (BIO)|NNNN: Projected Sales Volume|Sotera Health - Company Future Revenue|QDEL (quidel.com) - Projected Sales Volume|OPK: Company Future Revenue|Company Future Sales Volume CDNA (CareDx)|Projected Sales Volume Maravai LifeSciences (MRVI)|Fulgent Genetics, Inc. - Company Future Sales Volume|LAB: Company Revenue Forecast|Cytek Corp - Projected Sales Volume|Company Future Revenue OSUR (OraSure Technologies)|XGN: Projected Sales Volume|MDxHealth - Company Future Revenue|LUCD (luciddx.com) - Projected Sales Volume|PRE - Company Sales Forecast|Company Projected Revenue Insight Molecular Diagnostics Inc (IMDX)|TRIB - Company Expected Sales Volume|Projected Sales Volume PRPH (ProPhase Labs, Inc.)|Company Future Sales ainos.com (AIMD)|Co-Diagnostics Inc - Projected Sales Volume|HSCS - Projected Sales Volume|BMRA (Biomerica Inc) - Company Future Sales Volume|CDIO - Company Future Sales|Company Projected Revenue Onconetix Inc|VRAX - Company Sales Forecast|Company Future Sales Volume BJDX (Bluejay Diagnostics)|Accelerate Diagnostics Inc. - Company Revenue Forecast|Centogene - Company Future Sales Volume|Enzo Biochem, Inc. (ENZ) - Company Expected Sales Volume|Company Projected Revenue Volume Fresh2 Group Limited FRES|Company Future Sales gtglabs.com GENE|23andMe Holding Co (ME) - Company Projected Revenue|Company Revenue Forecast PMD